Novel Fluorophore Helps Reduce Surgical Risk in Patients Undergoing Prostatectomy

In this episode, host Rick Greene, MD, FACS, talks with Samuel A. Gold, MD, from the urology service in the Department of Surgery at Memorial Sloan Cancer Center in New York, New York, about using intraoperative fluorescence to illuminate nerve structures during robotic-assisted prostatectomy. Dr. Gold’s phase-1 study, published in JAMA Surgery (Rizedisben in Minimally Invasive Surgery), found that the fluorophore was generally well tolerated and clinically effective, which could revolutionize prostatic surgery and lead to wider applicability.

Talk about the podcast on social media using the hashtag #SurgicalReadings